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Intake of 7,8-dihydroxyflavone during juvenile and adolescent stages
prevents onset of psychosis in adult offspring after maternal immune
activation
Abstract

Prenatal infection and subsequent abnormal neurodevelopment of offspring is involved in the etiology of
schizophrenia. Brain-derived neurotrophic factor (BDNF) and its high affinity receptor, tropomyosin receptor
kinase B (TrkB) signaling plays a key role in the neurodevelopment. Pregnant mice exposed to
polyriboinosinic-polyribocytidylic acid [poly(I:C)] causes schizophrenia-like behavioral abnormalities in
their offspring at adulthood. Here we found that the juvenile offspring of poly(I:C)-treated mice showed
cognitive deficits, as well as reduced BDNF-TrkB signaling in the prefrontal cortex (PFC). Furthermore, the
adult offspring of poly(I:C)-treated mice showed cognitive deficits, prepulse inhibition (PPI) deficits, reduced
BDNF-TrkB signaling, immunoreactivity of parvalbumin (PV) and peroxisome proliferator-activated
receptor γ coactivator 1α (PGC-1α) in the prelimbic (PrL) of medial PFC and CA1 of hippocampus.
Supplementation of a TrkB agonist 7,8-dihydroxyflavone (1 mg/mL in drinking water) during juvenile and
adolescent stages could prevent these behavioral abnormalities, reduced BDNF-TrkB signaling in PFC and
CA1, and immunoreactivity of PV and PGC-1α in the PrL of medial PFC and CA1 in the adult offspring from
poly(I:C)-treated mice. These findings suggest that early intervention by a TrkB agonist in subjects with ultrahigh risk for psychosis may reduce the risk of subsequent transition to schizophrenia.
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Intake of 7,8-Dihydroxyflavone
During Juvenile and Adolescent
Stages Prevents Onset of Psychosis
in Adult Offspring After Maternal
Immune Activation
Mei Han1,2, Ji-chun Zhang1, Wei Yao1, Chun Yang1, Tamaki Ishima1, Qian Ren1, Min Ma1,
Chao Dong1, Xu-Feng Huang2 & Kenji Hashimoto1
Prenatal infection and subsequent abnormal neurodevelopment of offspring is involved in the etiology
of schizophrenia. Brain-derived neurotrophic factor (BDNF) and its high affinity receptor, tropomyosin
receptor kinase B (TrkB) signaling plays a key role in the neurodevelopment. Pregnant mice exposed to
polyriboinosinic-polyribocytidylic acid [poly(I:C)] causes schizophrenia-like behavioral abnormalities
in their offspring at adulthood. Here we found that the juvenile offspring of poly(I:C)-treated mice
showed cognitive deficits, as well as reduced BDNF-TrkB signaling in the prefrontal cortex (PFC).
Furthermore, the adult offspring of poly(I:C)-treated mice showed cognitive deficits, prepulse inhibition
(PPI) deficits, reduced BDNF-TrkB signaling, immunoreactivity of parvalbumin (PV) and peroxisome
proliferator-activated receptor γ coactivator 1α (PGC-1α) in the prelimbic (PrL) of medial PFC and CA1
of hippocampus. Supplementation of a TrkB agonist 7,8-dihydroxyflavone (1 mg/mL in drinking water)
during juvenile and adolescent stages could prevent these behavioral abnormalities, reduced BDNFTrkB signaling in PFC and CA1, and immunoreactivity of PV and PGC-1α in the PrL of medial PFC and
CA1 in the adult offspring from poly(I:C)-treated mice. These findings suggest that early intervention by
a TrkB agonist in subjects with ultra-high risk for psychosis may reduce the risk of subsequent transition
to schizophrenia.
Prenatal infection could be implicated in the etiology of schizophrenia1–4. Late adolescence and early adulthood
are peak times for the onset of schizophrenia as this period generally exposes substantial neurobiological changes
in the brain5–7. Cognitive impairment and social disabilities are often present before the onset of psychosis6,8–10.
Thus, there is increasing interest in the potential benefit of early pharmacological intervention in schizophrenia11.
Maternal immune activation (MIA) in rodents has a great impact on brain development and behavioral abnormalities in their offspring3,12–14. The offspring of prenatal rodents exposed to polyriboinosinic-polyribocytidylic
acid [poly(I:C)] mimics schizophrenia-like behavioral abnormalities in adulthood14,15. These deleterious effects in
the offspring after MIA can be prevented by treatment with antipsychotics (e.g., clozapine and risperidone) during the juvenile period16,17. However, early treatments with antipsychotics during juvenile and adolescent stages
caused long-term changes in cognition and neurobiology18,19. Thus, the use of antipsychotics during these stages
has detrimental side effects on the neurodevelopment process in humans. Therefore, it is necessary to develop safe
drugs for preventing the onset of schizophrenia.
Brain-derived neurotrophic factor (BDNF) and its high-affinity receptor tropomyosin receptor kinase B
(TrkB) signaling plays a key role in brain neurodevelopment20–22. Decreased serum BDNF levels have been found
in first-episode or chronic patients with schizophrenia23,24. Furthermore, the reduction of expression of BDNF
and TrkB receptor has been found in the prefrontal cortex and hippocampus of patients with schizophrenia25,26.
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The deficits in hippocampal BDNF expression are also found in placentas and offspring after maternal poly(I:C)
exposure during pregnancy in rodents12,27. These findings all suggest that decreased BDNF-TrkB signaling
plays a role in the pathophysiology of schizophrenia. The TrkB agonist 7,8-dihydroxyflavone (7,8-DHF) 28 has
shown neuroprotective and cognitive enhancing effects in animal models29–31. Therefore, it is of great interest to
examine whether supplementation with 7,8-DHF during juvenile and adolescent stages can prevent the onset of
schizophrenia-like behavioral abnormalities at adulthood in MIA offspring.
In the present study, we investigated whether the offspring of mice exposed to poly(I:C) in the prenatal
period show abnormal behaviors, BDNF-TrkB signaling, immunoreactivity of parvalbumin (PV) and peroxisome proliferator-activated receptor γcoactivator 1α (PGC-1α) in the brain regions, which are implicated in the
pathophysiology of schizophrenia25,26,32,33. Furthermore, we examined whether supplementation with 7,8-DHF
during juvenile and adolescent stages can prevent abnormal behaviors, decreased BDNF-TrkB signaling, and PV
and PGC-1αimmunoreactivity in adult MIA offspring.

Results

Cognitive Deficits and Decreased BDNF-TrkB Signaling in the Juvenile Offspring of Prenatal
Mice Exposed to Poly(I:C). We examined whether offspring from prenatal mice exposed to poly(I:C) could

cause abnormal behaviours and BDNF-TrkB signaling in the brain regions at juvenile stage (4–5- weeks old)
(Fig. 1a). In the locomotion test (LMT), there was no difference between poly(I:C)-treated offspring and controls
(P > 0.05) (Fig. 1b). The MANOVA analysis of PPI data did not reveal significant effects between two groups
(Wilks lambda =  0.874, P = 0.44) (Fig. 1c). In the novel object recognition test (NORT), there were no difference
between poly(I:C)-treated group and control group in the training session (P > 0.05). However, in the retention
session, exploratory preference of poly(I:C)-treated group was significantly lower than that of controls (P <  0.001)
(Fig. 1d), suggesting cognitive deficits of MIA offspring at juvenile stage.
BDNF-TrkB signaling plays a key role in many brain functions such as cognition20. To examine whether
BDNF-TrkB signaling plays a role in the cognitive deficits of juvenile offspring of poly(I:C)-treated group, we
measured the levels of BDNF, p-TrkB and TrkB in prefrontal cortex (PFC), nucleus accumbens (NAc) and CA1,
CA3, dentate gyrus (DG) of hippocampus in the juvenile offspring of two groups. The levels of BDNF and p-TrkB/
TrkB ratio in the PFC of poly(I:C)-treated group were significantly lower than those of controls (Fig. 1e,f). In contrast, the levels of BDNF and p-TrkB/TrkB ratio in the NAc, CA1, CA3 and DG of poly(I:C)-treated group were
not different from those of controls (Fig. 1e,f). These results suggest that decreased BDNF-TrkB signaling in the
PFC might play a role in the cognitive deficits of juvenile offspring of poly(I:C)-treated group.

Effect of Supplementation with 7,8-DHF on Behavioral Abnormalities at Adult Offspring of
Prenatal Mice Exposed to Poly(I:C). We examined whether supplementation with 7,8-DHF during juve-

nile and adolescent period stages could prevent the abnormal behavioural changes at adulthood. The offspring
for control and MIA groups were administrated with vehicle or 7,8-DHF (1 mg/mL in drinking water) from 4- to
8- weeks old. Subsequently, normal drinking water was given into all mice for additional 2-weeks (from 8- to
10-weeks old). Behavioural tests were performed at 10–12 weeks olds (Fig. 2a). Two-way ANOVA analysis of
LMT data revealed no differences (poly(I:C): F1,60 =  0.234, P = 0.630, 7,8-DHF: F1,60 =  0.358, P =  0.552, interaction: F1,60 =  0.086, P = 0.770) (Fig. 2b). The MANOVA analysis of all PPI data revealed that there were statistically
significant effects (Wilks lambda =  0.668, P = 0.031). Post-hoc test indicated that the poly(I:C) +  vehicle (VEH)
group had significantly lower PPI deficits than phosphate buffered saline (PBS) + VEH or poly(I:C) +  7,8-DHF
groups at all dB groups (Fig. 2c). Two-way ANOVA analysis of NORT data in the training session revealed no
significant interaction among four groups (poly(I:C): F1,51 =  0.000, P = 0.983, 7,8-DHF: F1,51 =  3.166, P =  0.081,
interaction: F1,51 =  0.668, P = 0.418) (Fig. 2d). In the retention session, two-way ANOVA analysis revealed a
significant effect among four groups (poly(I:C): F1,51 =  30.7, P = 0.000, 7,8-DHF: F1,51 =  6.712, P =  0.012, interaction:F1,51 =  21.2, P < 0.001) (Fig. 2d). Post-hoc test indicated that exploratory preference of poly(I:C) +  VEH
group was significantly lower than that of PBS + VEH or poly(I:C) + 7,8-DHF groups (Fig. 2d). These results
suggest that adult offspring from pregnant mice exposed to poly(I:C) showed PPI deficits and cognitive deficits at
adulthood, and that supplementation with 7,8-DHF from 4- to 8-weeks old could prevent the onset of PPI deficits
and cognitive deficits at adulthood after MIA.

Effect of Supplementation with 7,8-DHF on Decreased BDNF-TrkB Signaling at Adult Offspring
after Prenatal Mice Exposed to Poly(I:C). In this study, we examined whether supplementation with

7,8-DHF could attenuate decreased BDNF-TrkB signaling in the brain regions of adult offspring after MIA.
Two-way ANOVA analysis of BDNF data revealed significant effects (PFC, poly(I:C): F1,20 =  4.865, P =  0.039;
7,8-DHF: F1,20 =  4.426, P = 0.048; interaction: F1,20 =  6.396, P = 0.02), (CA1, poly(I:C): F1,20 =  4.841, P =  0.04,
7,8-DHF: F1,20 =  4.510, P = 0.046, interaction: F1,20 =  9.312, p = 0.006). Post-hoc analysis showed that the levels of
BDNF in the PFC and CA1 of the adult offspring from poly(I:C) + VEH group were significantly lower than those
of PBS + VEH or poly(I:C) + 7,8-DHF groups in the PFC and CA1 (Fig. 3a). In contrast, there were no differences
among the four groups in the other regions including NAc, CA3, and DG.
Two-way analysis of p-TrkB/TrkB ratio data revealed significant effects (PFC, poly(I:C): F1,20 =  5.824,
P = 0.026; 7,8-DHF: F1,20 =  5.305, P = 0.032, interaction: F1,20 =  9.683, P = 0.005) (CA1, poly(I:C): F1,20 =  5.578,
P = 0.028, 7,8-DHF: F1,20 =  5.24, P = 0.033, interaction: F1,20 =  4.89, P = 0.039). Post-hoc test showed that the
p-TrkB/TrkB ratio in the PFC and CA1 of adult offspring from poly(I:C) + VEH group was significantly lower
than that of PBS + VEH or poly(I:C) + 7,8-DHF groups (Fig. 3b). In contrast, there were no differences among
the four groups in the other regions including NAc, CA3, and DG.
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Figure 1. Behaviors and BDNF-TrkB signaling in the juvenile offspring of prenatal mice exposed to
poly(I:C). (a) Schedule of treatment, behavioral tests and western blot analysis. (b) LMT: there were no
differences between ploy I:C offspring and controls in locomotor activity. The value is expressed as the
mean ±  SEM. (n = 13 or 14). (c) PPI: there were no differences between poly I:C offspring and controls in the
PPI tasks. The value is expressed as the mean ±  SEM (n =  16). (d) NORT: the exploratory preferences were
significantly lower in the poly(I:C) offspring than controls in the retention session, but there was no difference
between the two groups in the training session. ***P < 0.001 compared with PBS treated group. The value is
expressed as the mean ±  SEM (n =  14). (e) BDNF: **P < 0.01 compared with PBS treated group. The value is
expressed as the mean ±  SEM (n =  6). (f) p-TrkB/TrkB ratio: **P < 0.01 compared with PBS treated group. The
value is expressed as the mean ±  SEM (n =  6).

These data suggest that adult offspring from prenatal mice exposed to poly(I:C) showed decreased BNDF-TrkB
signaling in the PFC and CA1 of hippocampus, but not NAc, CA3, DG of hippocampus, and that supplementation with 7,8-DHF could normalize decreased BDNF-TrkB signaling in these regions of adult offspring from
poly(I:C)-treated group.
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Figure 2. Effect of 7,8-DHF supplementation on behavioural abnormality in the adult offspring of prenatal
mice exposed to poly(I:C). (a) Schedule of treatment and behavioral tests. (b) LMT: there were no significant
differences among the four groups in the locomotor activity. The value is expressed as the mean ±  SEM (n =  13
or 14). N.S.: not significant. (c) PPI: *P <  0.05, **P < 0.01 compared with poly(I:C) + VEH group. The value is
expressed as the mean ±  SEM (n =  14–16). (d) NORT: ***P < 0.001 compared with poly(I:C) + VEH group. The
value is expressed as the mean ±  SEM (n = 13 or 14).

Effect of Supplementation with 7,8-DHF on Decreased PV-Immunoreactivity in the Brain at
Adult Offspring after Prenatal Mice Exposed to Poly(I:C). Loss of PV-positive cells is known to be

associated with cognitive deficits34. PV-immunohistochemistry was performed at adulthood (11-weeks old)
(Fig. 4a). Two-way ANOVA analysis revealed significant effects (PrL, poly(I:C): F1,20 =  29.12, P <  0.001; 7,8-DHF:
F1,20 =  4.722, P = 0.031; interaction: F1,20 =  4.311, P = 0.039) (CA1, poly(I:C): F1,20 =  18.203, P <  0.001, 7,8-DHF:
F1,20 =  4.245, P = 0.041, interaction: F1,20 =  11.722, P = 0.001). Post-hoc test showed that PV-immunoreactivity
in the PrL of medial PFC (mPFC) and CA1 of hippocampus (not IL, NAc, CA3, and DG) of poly(I:C) +  VEH
group was significantly lower than that of PBS + VEH or poly(I:C) + 7,8-DHF groups (Fig. 4b–d). These findings
suggest that adult offspring from prenatal mice exposed to poly(I:C) showed the loss of PV-immunoreactivity in
the PrL of mPFC and CA1, but not NAc, CA3, and DG, and that supplementation with 7,8-DHF could prevent
the loss of PV-immunoreactivity in these brain regions after MIA.

Effect of Supplementation with 7,8-DHF on Decreased PGC-1α Immunoreactivity in the Brain
at Adult Offspring after Prenatal Mice Exposed to Poly(I:C). PGC-1αis a master regulator of metab-

olism, and is associated with cellular growth, differentiation, and energy metabolism35. Furthermore, PGC-1α
may regulate the expression of PV within PV-interneurons in the cortex and hippocampus36,37. We also performed immunohistochemistry of PGC-1αin the brain regions (Fig. 5a,b). Two-way ANOVA analysis revealed
significant effects (PrL of mPFC, poly(I:C): F1,20 = 24.126, 7,8-DHF: P <  0.001, F1,20 =  3.89, P =  0.050, interaction: F1,20 =  8.284, P = 0.004)(CA1, poly(I:C): F1,2 0 =  7.126, P = 0.008, 7,8-DHF: F1,20 =  6.35, P =  0.013, interaction: F1,20 =  6.018, P = 0.015). Post-hoc test showed that PGC-1αimmunoreactivity in the PrL of mPFC and
CA1 (not IL, NAc, CA3, and DG) of poly(I:C) + VEH group was significantly lower than that of PBS +  VEH or
poly(I:C) + 7,8-DHF groups (Fig. 5a,b). These findings suggest that adult offspring from prenatal mice exposed
to poly(I:C) showed loss of PGC-1αimmunoreactivity in the PrL of mPFC and CA1, but not NAC, CA3, and DG,
and that supplementation with 7,8-DHF could prevent the loss of PGC-1αimmunoreactivity in these regions of
adult offspring after MIA.

Discussion

The major findings of the present study are as follows. Supplementation with 7,8-DHF during the juvenile and
adolescent stages of offspring of prenatal mice exposed to poly(I:C) led to the prevention of behavioral changes
(e.g., cognitive deficits and PPI deficits), decreased BDNF-TrkB signaling in PFC and CA1 of hippocampus, and
loss of PV and PGC-1αimmunoreactivity in the PrL of mPFC and CA1 of hippocampus at adulthood after MIA.
Therefore, it is likely that supplementation with a TrkB agonist such as 7,8-DHF during the prodromal stage has
prophylactic effects on the behavioral abnormalities relevant to schizophrenia and related disorders at adulthood.
In this study, we identified the cognitive deficits of offspring from poly(I:C)-treated mice at 4 weeks and 10
weeks of age. Since cognitive deficits are seen in young subjects with ultra-high risk for psychosis8,9, the juvenile
offspring from poly(I:C)-treated mice may be at the prodromal stage for psychosis. Furthermore, we noticed
Scientific Reports | 6:36087 | DOI: 10.1038/srep36087
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Figure 3. Effect of 7,8-DHF supplementation on decreased BDNF-TrkB signaling in the brain regions of
adult offspring of prenatal mice exposed to poly(I:C). (a) BDNF: **P <  0.01, ***P <  0.001 compared
with poly(I:C) + VEH group. The value is expressed as the mean ±  SEM (n = 5 or 6). N.S.: not significant.
(b) p-TrkB/TrkB: **P <  0.01, ***P < 0.001 compared with poly(I:C) + VEH group. The value is expressed as the
mean ±  SEM (n = 5 or 6). N.S.: not significant.

PPI deficits in offspring from poly(I:C)-treated mice at adulthood, but not in those at the juvenile stage. Because
PPI deficits in neural circuits might cause some symptoms of schizophrenia38,39, PPI deficits of adult offspring
from poly(I:C)-treated mice mimic PPI deficits in patients with schizophrenia40. Our findings are similar to the
behavioral abnormalities relevant to human psychiatric disorders including schizophrenia6,10,25. We found that
decreased BDNF-TrkB signaling in the PFC and CA1 of the hippocampus may play a role in the cognitive deficits observed in offspring from poly(I:C)-treated mice and that supplementation of 7,8-DHF at 4–8 weeks of
age (similar to juvenile and adolescent stages in human) in poly(I:C) offspring could treat or prevent cognitive
deficits and PPI deficits at adulthood after MIA. In contrast, we found an increase expression of Bdnf gene in the
PFC of offspring after poly(I:C) injection (Supplemental Fig. 1). It is likely that increase in Bdnf gene expression
in the PFC may be compensatory response to decreased expression of BDNF protein in the PFC of offspring
from poly(I:C)-treated mice. Prenatal infection may cause neurodevelopmental disorders in their offspring41,
and downregulation of BDNF-TrkB signaling may be involved in this abnormal brain neurodevelopment21,42,43.
We have reported that 7,8-DHF could attenuate behavioral abnormalities (e.g., hyperlocomotion, PPI deficits,
and behavioral sensitization) and dopaminergic neurotoxicity after methamphetamine administration44,45. These
results suggest that early treatment with a TrkB agonist during juvenile and adolescent stages may have prophylactic and therapeutic effects on behavioral abnormalities in several psychiatric disorders, including schizophrenia and substance abuse.
Adolescence is a critical period of neurodevelopment, and is also more vulnerable to psychiatric disorders5,7.
The study provides support for the deleterious effects of early brain insult on adult behaviors and brain neurodevelopment abnormalities46. Therefore, although adolescence is the peak time for the onset of a number of psychiatric disorders, cognitive deficits at an early age such as the juvenile stage may present prodromal symptoms
for later onset of psychiatric disorders. Supplementation with 7,8-DHF in young subjects at ultra-high risk for
psychosis may play an important role in preventing the onset of psychosis.
We observed loss of PV immunoreactivity in the PrL, but not IL (infralimbic), of mPFC and CA1 of hippocampus at adulthood after MIA, which is consistent with the findings of other rodent studies 47,48. Loss of
PV-positive cells in the PFC might contribute to the pathogenesis of schizophrenia33,34,49. Since TrkB is predominantly expressed by PV-containing neurons in the PFC and hippocampus, decreased BDNF-TrkB signaling in
PV-positive interneurons of PrL of mPFC and CA1 of hippocampus may play an important role in modulating
behavioral abnormalities in the offspring after MIA.
Further, we found loss of PGC-1αimmunoreactivity in the PrL, but not IL, of mPFC and CA1 of hippocampus in the adult offspring after MIA. The mPFC is a heterogeneous cortical structure composed of several nuclei,
including PrL and IL cortices50. PrL is mainly involved in cognitive function, whereas IL appears to represent
a visceromotor center homologous in primates50. PrL and IL play an important role in cognitive processes and
visceromotor functions, respectively. Therefore, loss of PV immunoreactivity in the PrL, but not IL, of mPFC
of adult offspring might be associated with cognitive deficits in MIA offspring. A recent study demonstrated a
reduction in PGC-1α-dependent transcripts (e.g., PV, synaptotagmin, and complexin 1) in the anterior cingulate
cortex from schizophrenia32. Furthermore, a recent study reported an abnormal alteration in the PGC-1α mRNA
expression in the PFC from patients with schizophrenia51. Taken together, it is likely that reductions in the PV and
PGC-1αimmunoreactivity in the PrL of mPFC and CA1 of offspring from poly(I:C)-treated mice may be associated with reduced BDNF-TrkB signaling in these regions, supporting the results of a previous study showing
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Figure 4. Effect of 7,8-DHF supplementation on loss of PV-immunoreactivity in the brain regions of
adult offspring of prenatal mice exposed to poly(I:C). (a) Schedule of treatment, behavioural tests and
immunohistochemistry. (b) Brain regions of the IL and PrL of mPFC, NAc, and CA1, CA3, DG of hippocampus
are shown. (c) PV-immunoreactivity: **P <  0.01, ***P < 0.001 compared with poly(I:C) + VEH group. The
value is expressed as the mean ±  SEM (n = 6). N.S.: not significant. (d) Representative photographs for PVimmunohistochemistry in the brain regions of adult offspring.

BDNF expression through PGC-1α52. However, precise studies reporting the underlying BDNF-TrkB signaling
through PGC-1αin neurodevelopment are needed.
In conclusion, supplementation of 7,8-DHF during juvenile and adolescent stages could prevent the onset of
behavioral abnormalities and loss of PV and PGC-1αimmunoreactivity in the PrL of mPFC and CA1 in the offspring after MIA. Therefore, supplementation of a TrkB agonist in young subjects at ultra-high risk for psychosis
may prevent conversion to psychosis.

Methods

Animals. Female ddY mice (pregnant 5 days) were purchased from SLC Japan (Hamamatsu, Shizuoka, Japan).
The first day after copulation was defined as embryonal day 0 (E0) of the pregnancy. Every 6 consecutive days
from E12 to E17, the pregnant mice were injected intraperitoneally (IP) with poly(I:C) (5.0 mg/kg) dissolved in
0.2 ml 1% PBS per 20 g body weight or an equivalent volume of PBS, as previously reported14. The offspring were
separated from their mothers after 3 weeks, and male mice were used for the experiment and caged separately in
groups of three to five. The mice were treated with VEH or 7,8-DHF (1 mg/mL) in drinking water for consecutive
from 4 to 8-weeks old. Subsequently, normal water was given into all mice from 8 to 10-weeks old. The mice were
housed in clear polycarbonate cages (22.5 ×  33.8 × 14.0 cm), under a controlled 12/12 hour light-dark cycle (lights
on from 07:00 am to 07:00 pm), with room temperature at 23 ± 1 °C and humidity at 55 ± 5%. The mice were
given free access to water and food pellets. All experiments were carried out in accordance with the Guide for
Animal Experimentation of Chiba University. The protocol was approved by the Chiba University Institutional
Animal Care and Use Committee.
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Figure 5. Effect of 7,8-DHF supplementation on loss of PGC-1α immunoreactivity in the brain regions of
adult offspring of prenatal mice exposed to poly(I:C). (a) PGC-1αimmunoreactivity: ***P <  0.001 compared
with poly(I:C) + VEH group. The value is expressed as the mean ±  SEM (n = 6). N.S.: not significant.
(b) Representative photographs for PGC-1α-immunohistochemistry in the brain regions of adult offspring.

Drugs. Poly(I:C) was purchased from CALBIOCHEM (San Diego, CA). 7,8-DHF was purchased from Tokyo

Chemical Industry Co., Ltd. (Tokyo, Japan), and were dissolved in phosphate buffered saline containing 17%
dimethyl sulfoxide (DMSO) to generate a stock solution at 100 mg/mL concentration. The stock solution (1 ml)
was added to 100 ml of Hydropac water that contained 1% sucrose (pH = 7.4), and subsequently was given to
mice as drinking water (1 mg/mL of 7,8-DHF). The dose of 7,8-DHF was selected as previously reported53. The
VEH contained the same concentration of sucrose and DMSO. The drinking water that contained either 7,8-DHF
or VEH was replaced every 2 days. Other drugs were purchased from commercial sources.

Behavioral tests. Locomotion (LMT). The mice were measured locomotor activity using an animal movement analysis system (SCANET MV-40; Melquest, Toyama, Japan) as reported previously54. The locomotion
activity was measured 60 min.

Prepulse inhibition (PPI). The mice were tested for their acoustic startle responses in a startle chamber (SR-LAB,
San Diego Instruments, San Diego, California, USA) using standard methods described previously54. The mice
were subjected to one of six trial types: (1) pulse alone, 40-millisecond broadband burst; pulse preceded 100 milliseconds by a 20-millisecond prepulse that was (2) 4 dB (PP69), (3) 8 dB (PP73), (4) 12 dB (PP77) and (5) 16 dB
(PP81) over background (65 dB); and (6) background only (no stimulus). The amount of PPI was expressed as
the percentage decrease in the amplitude of the startle response caused by presentation of the prepulse (%PPI).
Novel object recognition test (NORT). To assess the cognitive function, the mice were examined by NORT as
previously reported55. Each mouse habituated in the open field 10 minutes every time for 3 days before the training session. During the training session, two novel objects (differing in shape and colour but of similar size) were
placed into the box 35.5 cm apart (symmetrically), and each mouse was allowed to explore freely in the open field
for 10 minutes. The mice were considered to be exploring the object when the head of the mouse was touching or
standing on the object. The time that mice spent exploring each object was recorded. After training, mice were
immediately returned to their home cages, and the box and objects were cleaned with 75% ethanol, to avoid any
possible instinctive odorant cues. Retention tests were carried out at the same box 24 hour after the training session, and one of the familiar objects during training was replaced by a novel object. The mice were then allowed to
explore freely for 5 minutes, and the time spent exploring each object was recorded. Throughout the experiments,
the objects were counter-balanced, in terms of their physical complexity and emotional neutrality. A preference
index, a ratio of the amount of time spent exploring either of the two objects (training session) or the novel one
(retention session) over the total time spent exploring both objects, was used to measure recognition memory.
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Western blot analysis.

The brain samples of prefrontal cortex (PFC), CA1, CA3 and dentate gyrus (DG)
of the hippocampus, and nucleus accumbens (NAc) were prepared and Western blot analysis was performed as
described previously56–58. Basically, tissue samples were homogenized in Laemmli lysis buffer. Aliquots (10 μg)
of protein were measured using the DC protein assay kit (Bio-Rad, Hercules, CA, USA), and incubated for
5 min at 95 °C, with an equal volume of 125 mM Tris/HCl, pH 6.8, 20% glycerol, 0.1% bromophenol blue, 10%
β-mercaptoethanol, 4% sodium dodecyl sulfate, and subjected to sodium dodecyl sulfate polyacrylamide gel
electrophoresis, using 10% mini-gels (Mini-PROTEAN TGX Precast Gel; Bio-Rad, CA, USA). Proteins were
transferred onto polyvinylidenedifluoride (PVDF) membranes using a Trans Blot Mini Cell (Bio-Rad). For
immunodetection, the blots were blocked with 2% bovine serum albumin (BSA) in TBST (TBS +  0.1% Tween-20)
for 1 hour at room temperature (RT), and kept with primary antibodies overnight at 4 °C. The following primary
antibodies were used: BDNF (1:1000, H-117, Santa Cruz Biotechnology, Inc., CA, USA), phosphorylated-TrkB
(Tyr 706) (1:200, Santa Cruz Biotechnology), TrkB (80E3) (1:1000, Cell Signalling Technology, Danvers, MA,
USA) and β-actin (1:10000, Sigma-Aldrich). The next day, blots were washed three times in TBST and incubated
with horseradish peroxidase conjugated anti-rabbit antibody or anti-mouse antibody for 1 hour at room temperature. After final three washes with TBST, bands were detected using enhanced chemiluminescence (ECL) plus the
Western Blotting Detection system (GE Healthcare Bioscience, Tokyo, Japan). Images were captured with a Fuji
LAS3000-mini imaging system (Fujifilm, Tokyo, Japan) and immunoreactive bands were quantified.

®

™

Immunohistochemistry. Immunohistochemistry on the mouse brain sections was performed as the
reported previously57,59,60. Mice were deeply anesthetized with sodium pentobarbital and perfused transcardially
with 10 ml of isotonic saline, followed by 40 ml of ice-cold, 4% paraformaldehyde in a 0.1 M phosphate buffer
(pH 7.4). Brains were removed from the skulls and postfixed overnight at 4 °C in the same fixative. For the immunohistochemical analysis, 50 μm-thick serial, coronal sections of brain tissue were cut in ice-cold, 0.01 M phosphate buffered saline (pH 7.5) using a vibrating blade microtome (VT1000s, Leica Microsystems AG, Wetzlar,
Germany). Free-floating sections were treated with 0.3% H2O2 in 50 mM Tris-HCL saline (TBS) for 30 min and
were blocked in TBS containing 0.2% Triton X-100 (TBST) and 1.5% normal goat serum for 1 h at room temperature. The samples were then incubated for 24 h at 4 °C with rabbit polyclonal anti-PV antibody (1:2,500, Swant,
Bellinzona, Switzerland) or rabbit polyclonal anti-PGC-1αantibody (1:500, Abcam, Cambridge, MA, USA).
The sections were washed three times in TBS and then processed using the avidin-biotin-peroxidase method
(Vectastain Elite ABC, Vector Laboratories, Inc., Burlingame, CA, USA). Sections were incubated for 3 min in a
solution of 0.25 mg/mL diaminobenzidine containing 0.01% H2O2. Then, sections were mounted on gelatinized
slides, dehydrated, cleared, and coverslipped under Permount (Fisher Scientific, Fair Lawn, NJ, USA). The sections were imaged, and the staining intensity of PV or PGC-1αimmunoreactivity in the infralimbic (IL) and
prelimbic (PrL) of the medial prefrontal cortex (mPFC), nucleus accumbens (NAc), and hippocampus (CA1,
CA3, DG) regions were analyzed using a light micro-scope equipped with a CCD camera (Olymups IX70, Tokyo,
Japan) and the SCION IMAGE software package. Images of sections within mPFC (IL, PrL), NAc and hippocampal (CA1, CA3, DG) regions were captured using a 100×objective with a Keyence BZ-9000 Generation II microscope (Osaka, Japan).

®

Statistical Analysis. The data are expressed as the mean ± standard error of the mean (SEM). Analysis was

performed using PASW Statistics 20 (formerly SPSS Statistics; SPSS, Tokyo, Japan). For the offspring at 4 week
study, the locomotion, NORT and western blot were analysed between the control and poly(I:C) groups by using
a Student t-test. The PPI data were analysed by multivariate analysis of variance (MANOVA), followed by Student
t-test. At 10 weeks of study all data collected from the offspring including the locomotion, NORT, western blot
and immunohistochemistry results, were analysed by two-way ANOVA, followed by post hoc Fisher’s least significant difference (LSD) test. The PPI data was analysed by MANOVA, followed by a post hoc Fisher’s LSD test.
Statistical significance was set at P <  0.05.
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